Epidemiology of Huntington’s Disease in Latin America: A Systematic Review and Meta-analysis.
Objective: To calculate the pooled prevalence of Huntington's Disease in Latin America. Background: Latin America has played a crucial role in advancing our understanding of…Study of Relationship Between Homocysteine, Folic Acid And Vitamin B12 Levels In Serum of Juvenile HD Children.
Objective: Our objective is to estimate the level of Hcy ,vitamin B12 , folic acid with motor and non-motor symptoms in HD patients in school…Amyloid Pathology and its association with Cognitive Status in Huntington’s Disease
Objective: To investigate the presence of beta-amyloid pathology in Huntington's disease (HD) and its potential impact on patients' cognitive status. Background: Recent evidence indicates that…Skin Tau Quantification as a Novel Biomarker in Huntington’s Disease
Objective: To explore skin tau quantification as a potential biomarker for disease severity, motor and cognitive function in Huntington's disease Background: Beyond the aggregation of…Nocturnal Blood Pressure, Non-Dipping, Psychosis And Non-Motor Symptoms In Early Stages Of Huntington’s Disease Patients
Objective: The aim of this study was to determine the relationship between 24 h ambulatory blood pressure measurements (ABPM), i.e., absence or presence of nocturnal…Exploring Correlations between Mutant Huntingtin, NfL, and MRI in Huntington’s Disease: A Multimodal Analysis
Objective: This study aims to investigate correlations between mHtt and NfL levels and MRI findings in individuals at different stages of HD, including presymptomatic and…Physical Activity Levels and Demographic Characteristics in Individuals with Huntington’s Disease: Insights from the ENROLL-HD Database in an Argentinian Movement Disorder Center
Objective: To assess PA levels in individuals enrolled in the ENROLL-HD database, and compare demographic characteristics between PE practitioners, and non-practitioners Background: Neurological disorders have been…Huntington’s Disease Pathogenesis, Molecular Factors, and Potential for Combinatorial Therapies: A Focus on BDNF and NMDA Receptor Therapies
Objective: This paper outlines current therapeutic options for HD, and ultimately suggests taking a combinatorial therapeutic approach to slow HD progression by simultaneously treating multiple…Localisation of distinct brain networks in premanifest and manifest Huntington’s disease
Objective: To map the brain networks underlying Huntington’s Disease (HD), testing whether there are distinct networks involved in premanifest and manifest disease stages. Background: HD…Autoimmune Chorea. Therapy with Monoclonal Antibodies: Experimental and Clinical Approach
Objective: Autoimmune chorea (AICh) resulting from the appearance of paraneoplastic antibodies in response to development of malignant tumors of various localization. Sydenham's rheumatic chorea, described…
- 1
- 2
- 3
- …
- 5
- Next Page »